Dysregulated NF-κB activation has been linked with various inflammatory disease states, including Alzheimer’s disease, arthritis, asthma, atherosclerosis, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and inflammatory bowel disease [30]. This evidence concerns the gene NFKB1 and pulmonary fibrosis.